Puma Biotechnology, Inc.
(NASDAQ : PBYI)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
LLYEli Lilly & Co. 1.08%365.631.1%$1192.52m
JNJJohnson & Johnson 0.12%177.220.7%$1097.25m
MRKMerck & Co., Inc. 0.60%107.460.7%$994.87m
PFEPfizer Inc. 0.72%49.200.9%$981.12m
ABBVAbbVie, Inc. 0.14%159.611.9%$906.78m
BMYBristol-Myers Squibb Co. 0.16%79.271.1%$751.13m
AZNAstraZeneca Plc 0.08%66.171.0%$360.17m
IDXXIDEXX Laboratories, Inc. -1.24%411.363.9%$222.64m
GSKGSK Plc 0.89%33.990.3%$202.02m
HZNPHorizon Therapeutics Plc 0.97%78.285.4%$201.37m
NVSNovartis AG 0.57%87.790.2%$190.04m
CTLTCatalent, Inc. -1.83%41.411.9%$163.88m
ALNYAlnylam Pharmaceuticals, Inc. 2.03%212.728.0%$159.13m
NVONovo Nordisk A/S 0.86%118.840.1%$155.62m
SGENSeagen Inc. -0.42%123.445.7%$122.67m

Company Profile

Puma Biotechnology, Inc. is a biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. It focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. The company was founded by Alan H. Auerbach on September 15, 2010 and is headquartered in Los Angeles, CA.